Legal and Regulatory Requirements for Cannabidiol (CBD) Based Pharmaceuticals and Related Products
Date: September 20, 2018
Duration: 60 Minutes
Time: 12 PM EST
Cannabidiol (CBD) is a highly regulated and highly attractive active ingredient of several products regulated by FDA, EMA and other regulators worldwide.
Now found in many products such as as cosmetics, dietary supplements, pet treats, vape pens, and investigational pharmaceuticals, cannabidiol (CBD) has clearly captured the attention of consumers and industry. Manufacturers, marketers, retailers, and consumers have shown increased interest in products containing cannabidiol (CBD). However, much confusion remains about the US and European legal and regulatory status of the ingredient, potential sources, and the various types of products in which companies include the ingredient.
CBD has also generated equal amounts of controversy and confusion. Chief among stakeholders’ concerns is the ingredient’s status under international law. The rules governing these products have several areas of confusion.
This session by expert speaker Dr. Mukesh Kumar will frame the issues in plain language, helping you understand the merits and vulnerabilities of these competing positions, the factors that matter in determining the status of a particular CBD-containing product, and the issues that remain unsettled.
Topics Covered in the Session:
- What cannabidiol is
- The European, Canadian and other international regulations for such products
- If CBD “marijuana” is subject to DEA enforcement
- GMP Requirements for CBD based products
- Discussion of “industrial hemp” and the “Farm Bill”
- The status of a CBD product under US and European laws
The session will focus on the requirements of the FDA, EMA and other regulators. You will be better informed to navigate the complex federal rules that determine the legal and regulatory status of CBD and various CBD-containing products. You will be better able to evaluate and mitigate the risks presented by certain CBD business opportunities. You will get risk-mitigation strategies for operating in the CBD industry, and understand the legal questions that remain unanswered and require continued monitoring. You will also gain the background needed to monitor and contextualize new developments in federal law, regulation, and policy impacting the CBD market.
Who will benefit:
This webinar will provide valuable assistance to all personnel in:
- Employees of manufacturers, distributors, and retailers of CBD products
- Attorneys
- Regulatory affairs specialists
- Marketing professionals serving the industry
- Investors
- Entrepreneurs
- Scientists
- Government employees interested in learning more about regulation of the category
Speaker: Mukesh Kumar
PhD, RAC | CEO, FDAMap
For more info, fill the box below. We will contact you within 24 hrs.
Webinar Fee
Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.
Terms & Conditions to register for the Webinar
Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com
Payment
We accept credit card, debit card, and PayPal.
Cancellations & Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.
Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.
In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.
